Xenetic Biosciences XBIO
NASDAQ XBIO
$2.02 +0.00 (+0.25%)
As of: Oct 21, 2026 · 3:59 PM EDT

Xenetic Biosciences (XBIO) Long-Term Debt Repayments (2015 - 2016)

Updated

Xenetic Biosciences (XBIO) posted Long-Term Debt Repayments of $137,699 for Q4 2016.

Analysis

Xenetic Biosciences (XBIO) Long-Term Debt Repayments (2015 - 2016) Analysis & Trends

For FY2016, Xenetic Biosciences' Long-Term Debt Repayments came in at $380,170, up 280.2% from FY2015.

  • Annual Long-Term Debt Repayments shows a four-year compound annual growth rate of -14.3% (FY2012 to FY2016).
  • In prior years, Xenetic Biosciences' Long-Term Debt Repayments was $100,000 in FY2015 (-65.1%), $286,124 in FY2014 and $706,201 in FY2012.
  • Quarterly Long-Term Debt Repayments has run from a low of $5,423 in Q2 2016 to a high of $237,048 in Q1 2016 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Xenetic Biosciences 4.61 Mn -21.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 507,657.00
Jun 30, 2016 5,423.00
Mar 31, 2016 237,048.00
Sep 30, 2015 100,000.00
API Access

Xenetic Biosciences Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=XBIO&period=max&api_key=YOUR_API_KEY